Combination therapy with famciclovir and interferon-α for the treatment of chronic hepatitis B

Journal of Infectious Diseases

Volumn 178, Issue 5 SUPPL., 1998, Pages 1483-1487

  Marques, Adriana R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; FAMCICLOVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PENCICLOVIR; PRODRUG; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DNA REPLICATION; DRUG EFFICACY; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

2-AMINOPURINE; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; DNA, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE;

EID: 0031753523     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314430     Document Type: Article

References (4)

1. The world health report 1996 - fighting disease, fostering development. World Health Forum 1997;18:1-8.
2. Korba BE, Boyd MR. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. Antimicrob Agents Chemother 1996;40:1282-4.
3. Lin E, Luscombe C, Wang YY, Shaw T, Locarnini S. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo. Antimicrob Agents Chemother 1996;40:413-8.
4. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.